Low-dose aminoglutethimide with and without hydrocortisone replacement as a first-line endocrine treatment in advanced breast cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples